Episode
Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances
- Published
- May 23, 2026
- Duration seconds
- 3522
- Processing state
not_requested- Canonical source
- https://oncologytoday.captivate.fm/episode/5911-yir2025-btkicll
Actions
POST https://stenobird.com/v1/public/podcasts/oncology-today-with-dr-neil-love-1004241/episodes/bruton-tyrosine-kinase-inhibitors-for-chronic-lymphocytic-leukemia-year-in-review-series-on-relevant-new-datasets-and-advances/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241/bruton-tyrosine-kinase-inhibitors-for-chronic-lymphocytic-leukemia-year-in-review-series-on-relevant-new-datasets-and-advances.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dr Jennifer R Brown and Prof Wojciech Jurczak discuss the selection and sequencing of Bruton tyrosine kinase-targeted therapy for patients with chronic lymphocytic leukemia and summarize major advances in the treatment landscape over the past year. CME information and select publications here .